Substance / Medication

Enalapril

Overview

Active Ingredient
enalapril
RxNorm CUI
3827

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

22 trials linked to this intervention

22
Total Trials
2
Recruiting
8
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Clinical Pharmacokinetics of Enalapril and Enalaprilat in Pediatric Patients-A Systematic Review.
Faisal Muhammad, Cawello Willi, Laeer Stephanie et al. · Front Pediatr · 2021
PMID: 33643971Meta-AnalysisFull text (PMC)
Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review.
Zhang Yili, Liu Junjie, Li Yuan et al. · Front Pharmacol · 2020
PMID: 32536868Meta-AnalysisFull text (PMC)
Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Rizzoni Damiano · Curr Med Res Opin · 2016
PMID: 27779457Meta-Analysis
Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
He Yuan-Mei, Feng Li, Huo Dong-Mei et al. · Nephrology (Carlton) · 2013
PMID: 23869492Meta-Analysis
[Enalapril-clinical experience in Bulgaria].
Taseva T · Vutr Boles · 2000
PMID: 11227662Meta-Analysis
Efficacy and Safety of Enalapril and Propranolol on Neurologic Recovery After Isolated Severe Traumatic Brain Injury: A Randomized Clinical Trial.
Mahmoodkhani Mehdi, Sahraei Ahmad, Shafiei Mehdi et al. · World Neurosurg · 2025
PMID: 40404011RCT
Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial.
Echeverria Luis Eduardo, Bocchi Edimar, Demacq Caroline et al. · Eur J Heart Fail · 2025
PMID: 40916703RCT
Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension.
Sychev Ivan V, Denisenko Natalia P, Kachanova Anastasiya A et al. · Int J Risk Saf Med · 2024
PMID: 37742663RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Enalapril (substance)
SNOMED CT
372658000
UMLS CUI
C0014025
RxNorm CUI
3827

Clinical Data

This intervention maps to 16 entities in the Ltrl knowledge graph.

5
Conditions
5
Biomarkers
3
Specialists
0
Symptoms
22
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.